Inspector/manufacturer communication encouraged as part of FDA compliance "culture change".
This article was originally published in The Gray Sheet
Executive Summary
FDA INVESTIGATOR/MANUFACTURER DISCUSSION OF ADVERSE FINDINGS DURING INSPECTIONS is being encouraged by the agency, FDA Deputy Commissioner for Regulatory Affairs Gary Dykstra said Sept. 20 during a "Compliance Video Conference" sponsored by FDA and the Food and Drug Law Institute. FDA is emphasizing to its field inspectors that they should "discuss things more openly with the firm as they are doing their investigation."
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.